UniProt ID | RAD18_HUMAN | |
---|---|---|
UniProt AC | Q9NS91 | |
Protein Name | E3 ubiquitin-protein ligase RAD18 | |
Gene Name | RAD18 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 495 | |
Subcellular Localization | Nucleus . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Associates with chromatin (PubMed:25931565). Colocalizes with SLF1 in the nucleus and to centrosomes (PubMed:15632077). Relocalizes with SLF1 to nuclear foci in response t | |
Protein Description | E3 ubiquitin-protein ligase involved in postreplication repair of UV-damaged DNA. Postreplication repair functions in gap-filling of a daughter strand on replication of damaged DNA. Associates to the E2 ubiquitin conjugating enzyme UBE2B to form the UBE2B-RAD18 ubiquitin ligase complex involved in mono-ubiquitination of DNA-associated PCNA on 'Lys-164'. Has ssDNA binding activity.. | |
Protein Sequence | MDSLAESRWPPGLAVMKTIDDLLRCGICFEYFNIAMIIPQCSHNYCSLCIRKFLSYKTQCPTCCVTVTEPDLKNNRILDELVKSLNFARNHLLQFALESPAKSPASSSSKNLAVKVYTPVASRQSLKQGSRLMDNFLIREMSGSTSELLIKENKSKFSPQKEASPAAKTKETRSVEEIAPDPSEAKRPEPPSTSTLKQVTKVDCPVCGVNIPESHINKHLDSCLSREEKKESLRSSVHKRKPLPKTVYNLLSDRDLKKKLKEHGLSIQGNKQQLIKRHQEFVHMYNAQCDALHPKSAAEIVREIENIEKTRMRLEASKLNESVMVFTKDQTEKEIDEIHSKYRKKHKSEFQLLVDQARKGYKKIAGMSQKTVTITKEDESTEKLSSVCMGQEDNMTSVTNHFSQSKLDSPEELEPDREEDSSSCIDIQEVLSSSESDSCNSSSSDIIRDLLEEEEAWEASHKNDLQDTEISPRQNRRTRAAESAEIEPRNKRNRN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDSLAESR -------CCCHHHHC | 7.73 | 22814378 | |
16 | Ubiquitination | WPPGLAVMKTIDDLL CCCCHHHHHHHHHHH | 2.36 | 21890473 | |
17 | Ubiquitination | PPGLAVMKTIDDLLR CCCHHHHHHHHHHHH | 35.41 | 33845483 | |
24 | Ubiquitination | KTIDDLLRCGICFEY HHHHHHHHCCCCHHH | 24.74 | 23000965 | |
29 | Ubiquitination | LLRCGICFEYFNIAM HHHCCCCHHHCCEEE | 8.90 | 23000965 | |
41 | Ubiquitination | IAMIIPQCSHNYCSL EEEECHHCCCCCHHH | 3.61 | 27667366 | |
52 | Acetylation | YCSLCIRKFLSYKTQ CHHHHHHHHHHCCCC | 30.64 | 26051181 | |
52 | Ubiquitination | YCSLCIRKFLSYKTQ CHHHHHHHHHHCCCC | 30.64 | 21963094 | |
55 | Phosphorylation | LCIRKFLSYKTQCPT HHHHHHHHCCCCCCC | 27.93 | 28152594 | |
56 | Phosphorylation | CIRKFLSYKTQCPTC HHHHHHHCCCCCCCE | 21.87 | 25884760 | |
57 | Acetylation | IRKFLSYKTQCPTCC HHHHHHCCCCCCCEE | 28.83 | 26051181 | |
57 | Ubiquitination | IRKFLSYKTQCPTCC HHHHHHCCCCCCCEE | 28.83 | 21963094 | |
58 | Phosphorylation | RKFLSYKTQCPTCCV HHHHHCCCCCCCEEE | 27.46 | 28152594 | |
62 | Phosphorylation | SYKTQCPTCCVTVTE HCCCCCCCEEEEECC | 26.60 | 28152594 | |
65 | Ubiquitination | TQCPTCCVTVTEPDL CCCCCEEEEECCCCC | 5.40 | 23000965 | |
66 | Phosphorylation | QCPTCCVTVTEPDLK CCCCEEEEECCCCCC | 14.06 | 28152594 | |
68 | Ubiquitination | PTCCVTVTEPDLKNN CCEEEEECCCCCCCC | 32.22 | 23000965 | |
70 | Ubiquitination | CCVTVTEPDLKNNRI EEEEECCCCCCCCHH | 42.75 | 23000965 | |
73 | Ubiquitination | TVTEPDLKNNRILDE EECCCCCCCCHHHHH | 60.60 | 21963094 | |
75 | Ubiquitination | TEPDLKNNRILDELV CCCCCCCCHHHHHHH | 30.68 | 23000965 | |
82 | Ubiquitination | NRILDELVKSLNFAR CHHHHHHHHHHHHHH | 3.58 | 22817900 | |
83 | Ubiquitination | RILDELVKSLNFARN HHHHHHHHHHHHHHH | 62.95 | 23000965 | |
84 | Ubiquitination | ILDELVKSLNFARNH HHHHHHHHHHHHHHH | 22.52 | 22817900 | |
99 | Phosphorylation | LLQFALESPAKSPAS HHHHHHHCCCCCCCC | 30.89 | 22167270 | |
100 | Ubiquitination | LQFALESPAKSPASS HHHHHHCCCCCCCCC | 34.04 | 23000965 | |
102 | Sumoylation | FALESPAKSPASSSS HHHHCCCCCCCCCCC | 61.43 | - | |
102 | Sumoylation | FALESPAKSPASSSS HHHHCCCCCCCCCCC | 61.43 | - | |
102 | Ubiquitination | FALESPAKSPASSSS HHHHCCCCCCCCCCC | 61.43 | 21963094 | |
103 | Phosphorylation | ALESPAKSPASSSSK HHHCCCCCCCCCCCC | 28.01 | 23927012 | |
106 | Phosphorylation | SPAKSPASSSSKNLA CCCCCCCCCCCCCEE | 33.85 | 26503892 | |
107 | Phosphorylation | PAKSPASSSSKNLAV CCCCCCCCCCCCEEE | 40.51 | 23927012 | |
108 | Phosphorylation | AKSPASSSSKNLAVK CCCCCCCCCCCEEEE | 42.72 | 23927012 | |
109 | Phosphorylation | KSPASSSSKNLAVKV CCCCCCCCCCEEEEE | 27.75 | 23927012 | |
110 | Sumoylation | SPASSSSKNLAVKVY CCCCCCCCCEEEEEE | 58.91 | - | |
110 | Sumoylation | SPASSSSKNLAVKVY CCCCCCCCCEEEEEE | 58.91 | - | |
110 | Ubiquitination | SPASSSSKNLAVKVY CCCCCCCCCEEEEEE | 58.91 | 23000965 | |
111 | Ubiquitination | PASSSSKNLAVKVYT CCCCCCCCEEEEEEC | 34.87 | 23000965 | |
115 | Sumoylation | SSKNLAVKVYTPVAS CCCCEEEEEECCCCC | 24.74 | - | |
115 | Sumoylation | SSKNLAVKVYTPVAS CCCCEEEEEECCCCC | 24.74 | - | |
115 | Ubiquitination | SSKNLAVKVYTPVAS CCCCEEEEEECCCCC | 24.74 | 23000965 | |
117 | Phosphorylation | KNLAVKVYTPVASRQ CCEEEEEECCCCCHH | 10.29 | 28796482 | |
118 | Phosphorylation | NLAVKVYTPVASRQS CEEEEEECCCCCHHH | 17.80 | 25159151 | |
122 | Phosphorylation | KVYTPVASRQSLKQG EEECCCCCHHHHHHC | 30.96 | 25159151 | |
125 | Phosphorylation | TPVASRQSLKQGSRL CCCCCHHHHHHCCCH | 36.10 | 25159151 | |
127 | Sumoylation | VASRQSLKQGSRLMD CCCHHHHHHCCCHHH | 58.84 | - | |
127 | Sumoylation | VASRQSLKQGSRLMD CCCHHHHHHCCCHHH | 58.84 | - | |
127 | Ubiquitination | VASRQSLKQGSRLMD CCCHHHHHHCCCHHH | 58.84 | 27667366 | |
130 | O-linked_Glycosylation | RQSLKQGSRLMDNFL HHHHHHCCCHHHHHH | 21.53 | 30379171 | |
132 | Ubiquitination | SLKQGSRLMDNFLIR HHHHCCCHHHHHHHH | 5.60 | 21963094 | |
141 | Sulfoxidation | DNFLIREMSGSTSEL HHHHHHHCCCCHHHH | 3.85 | 21406390 | |
142 | Phosphorylation | NFLIREMSGSTSELL HHHHHHCCCCHHHHH | 25.49 | 25159151 | |
144 | Phosphorylation | LIREMSGSTSELLIK HHHHCCCCHHHHHHH | 22.81 | 28555341 | |
145 | Phosphorylation | IREMSGSTSELLIKE HHHCCCCHHHHHHHH | 29.73 | 26074081 | |
146 | Phosphorylation | REMSGSTSELLIKEN HHCCCCHHHHHHHHC | 28.13 | 26074081 | |
151 | Sumoylation | STSELLIKENKSKFS CHHHHHHHHCHHCCC | 56.03 | - | |
151 | Sumoylation | STSELLIKENKSKFS CHHHHHHHHCHHCCC | 56.03 | - | |
151 | Ubiquitination | STSELLIKENKSKFS CHHHHHHHHCHHCCC | 56.03 | 23000965 | |
153 | Ubiquitination | SELLIKENKSKFSPQ HHHHHHHCHHCCCCC | 49.23 | 23000965 | |
154 | Ubiquitination | ELLIKENKSKFSPQK HHHHHHCHHCCCCCC | 56.99 | 23000965 | |
155 | Phosphorylation | LLIKENKSKFSPQKE HHHHHCHHCCCCCCC | 50.98 | 30266825 | |
155 | Ubiquitination | LLIKENKSKFSPQKE HHHHHCHHCCCCCCC | 50.98 | 23000965 | |
156 | Ubiquitination | LIKENKSKFSPQKEA HHHHCHHCCCCCCCC | 52.01 | 23000965 | |
158 | Phosphorylation | KENKSKFSPQKEASP HHCHHCCCCCCCCCC | 30.11 | 23401153 | |
159 | Ubiquitination | ENKSKFSPQKEASPA HCHHCCCCCCCCCCC | 53.01 | 21890473 | |
161 | Ubiquitination | KSKFSPQKEASPAAK HHCCCCCCCCCCCCC | 59.64 | 23000965 | |
164 | O-linked_Glycosylation | FSPQKEASPAAKTKE CCCCCCCCCCCCCCC | 19.03 | 30379171 | |
164 | Phosphorylation | FSPQKEASPAAKTKE CCCCCCCCCCCCCCC | 19.03 | 23401153 | |
168 | Ubiquitination | KEASPAAKTKETRSV CCCCCCCCCCCCCCH | 63.34 | 21906983 | |
169 | Phosphorylation | EASPAAKTKETRSVE CCCCCCCCCCCCCHH | 29.41 | 29449344 | |
170 | Ubiquitination | ASPAAKTKETRSVEE CCCCCCCCCCCCHHH | 57.28 | 22817900 | |
171 | Ubiquitination | SPAAKTKETRSVEEI CCCCCCCCCCCHHHH | 55.47 | 22817900 | |
172 | Phosphorylation | PAAKTKETRSVEEIA CCCCCCCCCCHHHHC | 29.78 | 25627689 | |
172 | Ubiquitination | PAAKTKETRSVEEIA CCCCCCCCCCHHHHC | 29.78 | 22817900 | |
173 | Ubiquitination | AAKTKETRSVEEIAP CCCCCCCCCHHHHCC | 39.53 | 22817900 | |
174 | Phosphorylation | AKTKETRSVEEIAPD CCCCCCCCHHHHCCC | 41.10 | 20873877 | |
175 | Ubiquitination | KTKETRSVEEIAPDP CCCCCCCHHHHCCCH | 7.44 | 21963094 | |
185 | Ubiquitination | IAPDPSEAKRPEPPS HCCCHHHCCCCCCCC | 19.93 | 21890473 | |
186 | Sumoylation | APDPSEAKRPEPPST CCCHHHCCCCCCCCC | 65.52 | - | |
186 | Sumoylation | APDPSEAKRPEPPST CCCHHHCCCCCCCCC | 65.52 | - | |
186 | Ubiquitination | APDPSEAKRPEPPST CCCHHHCCCCCCCCC | 65.52 | 23000965 | |
190 | Ubiquitination | SEAKRPEPPSTSTLK HHCCCCCCCCCCCCC | 30.72 | 22817900 | |
192 | Phosphorylation | AKRPEPPSTSTLKQV CCCCCCCCCCCCCCC | 45.78 | 28555341 | |
194 | Phosphorylation | RPEPPSTSTLKQVTK CCCCCCCCCCCCCCC | 35.76 | 25627689 | |
195 | Phosphorylation | PEPPSTSTLKQVTKV CCCCCCCCCCCCCCC | 37.75 | 25627689 | |
197 | Sumoylation | PPSTSTLKQVTKVDC CCCCCCCCCCCCCCC | 42.69 | - | |
197 | Sumoylation | PPSTSTLKQVTKVDC CCCCCCCCCCCCCCC | 42.69 | - | |
197 | Ubiquitination | PPSTSTLKQVTKVDC CCCCCCCCCCCCCCC | 42.69 | 23000965 | |
201 | Sumoylation | STLKQVTKVDCPVCG CCCCCCCCCCCCCCC | 36.90 | - | |
201 | Sumoylation | STLKQVTKVDCPVCG CCCCCCCCCCCCCCC | 36.90 | - | |
201 | Ubiquitination | STLKQVTKVDCPVCG CCCCCCCCCCCCCCC | 36.90 | 23000965 | |
218 | Ubiquitination | IPESHINKHLDSCLS CCHHHHHHHHHHHCC | 44.96 | 21906983 | |
223 | Ubiquitination | INKHLDSCLSREEKK HHHHHHHHCCHHHHH | 3.90 | 23000965 | |
229 | Sumoylation | SCLSREEKKESLRSS HHCCHHHHHHHHHHH | 58.02 | - | |
229 | Sumoylation | SCLSREEKKESLRSS HHCCHHHHHHHHHHH | 58.02 | - | |
229 | Ubiquitination | SCLSREEKKESLRSS HHCCHHHHHHHHHHH | 58.02 | - | |
232 | Ubiquitination | SREEKKESLRSSVHK CHHHHHHHHHHHHHC | 37.65 | 23000965 | |
235 | Phosphorylation | EKKESLRSSVHKRKP HHHHHHHHHHHCCCC | 41.84 | 25627689 | |
236 | Phosphorylation | KKESLRSSVHKRKPL HHHHHHHHHHCCCCC | 23.08 | 28348404 | |
239 | Ubiquitination | SLRSSVHKRKPLPKT HHHHHHHCCCCCCHH | 61.02 | 23000965 | |
241 | Acetylation | RSSVHKRKPLPKTVY HHHHHCCCCCCHHHH | 56.56 | 26051181 | |
241 | Ubiquitination | RSSVHKRKPLPKTVY HHHHHCCCCCCHHHH | 56.56 | 23000965 | |
242 | Ubiquitination | SSVHKRKPLPKTVYN HHHHCCCCCCHHHHH | 58.91 | 23000965 | |
245 | Ubiquitination | HKRKPLPKTVYNLLS HCCCCCCHHHHHHCC | 59.30 | 23000965 | |
247 | Ubiquitination | RKPLPKTVYNLLSDR CCCCCHHHHHHCCCH | 3.58 | 23000965 | |
254 | Methylation | VYNLLSDRDLKKKLK HHHHCCCHHHHHHHH | 48.03 | 115490091 | |
255 | Ubiquitination | YNLLSDRDLKKKLKE HHHCCCHHHHHHHHH | 68.76 | 23000965 | |
257 | Sumoylation | LLSDRDLKKKLKEHG HCCCHHHHHHHHHCC | 52.75 | - | |
257 | Sumoylation | LLSDRDLKKKLKEHG HCCCHHHHHHHHHCC | 52.75 | - | |
257 | Ubiquitination | LLSDRDLKKKLKEHG HCCCHHHHHHHHHCC | 52.75 | 21906983 | |
258 | Ubiquitination | LSDRDLKKKLKEHGL CCCHHHHHHHHHCCC | 71.31 | 23000965 | |
259 | Ubiquitination | SDRDLKKKLKEHGLS CCHHHHHHHHHCCCC | 64.30 | 23000965 | |
261 | Sumoylation | RDLKKKLKEHGLSIQ HHHHHHHHHCCCCCC | 57.45 | - | |
261 | Sumoylation | RDLKKKLKEHGLSIQ HHHHHHHHHCCCCCC | 57.45 | - | |
261 | Ubiquitination | RDLKKKLKEHGLSIQ HHHHHHHHHCCCCCC | 57.45 | 23000965 | |
271 | Ubiquitination | GLSIQGNKQQLIKRH CCCCCCCHHHHHHHH | 46.36 | 27667366 | |
276 | Ubiquitination | GNKQQLIKRHQEFVH CCHHHHHHHHHHHHH | 53.04 | 22817900 | |
284 | Ubiquitination | RHQEFVHMYNAQCDA HHHHHHHHHHHCCCC | 2.01 | 21890473 | |
290 | Ubiquitination | HMYNAQCDALHPKSA HHHHHCCCCCCCCCH | 39.83 | 21963094 | |
297 | Ubiquitination | DALHPKSAAEIVREI CCCCCCCHHHHHHHH | 18.42 | 21963094 | |
309 | Ubiquitination | REIENIEKTRMRLEA HHHHHHHHHHHHHHH | 37.32 | 23000965 | |
318 | Sumoylation | RMRLEASKLNESVMV HHHHHHHHCCCCEEE | 63.48 | - | |
318 | Sumoylation | RMRLEASKLNESVMV HHHHHHHHCCCCEEE | 63.48 | - | |
318 | Ubiquitination | RMRLEASKLNESVMV HHHHHHHHCCCCEEE | 63.48 | 23000965 | |
322 | Phosphorylation | EASKLNESVMVFTKD HHHHCCCCEEEEECC | 17.91 | 30266825 | |
327 | Phosphorylation | NESVMVFTKDQTEKE CCCEEEEECCCCHHH | 23.46 | 30266825 | |
328 | Sumoylation | ESVMVFTKDQTEKEI CCEEEEECCCCHHHH | 36.05 | - | |
328 | Sumoylation | ESVMVFTKDQTEKEI CCEEEEECCCCHHHH | 36.05 | - | |
328 | Ubiquitination | ESVMVFTKDQTEKEI CCEEEEECCCCHHHH | 36.05 | 23000965 | |
333 | Ubiquitination | FTKDQTEKEIDEIHS EECCCCHHHHHHHHH | 64.46 | 23000965 | |
341 | Acetylation | EIDEIHSKYRKKHKS HHHHHHHHHHHHCHH | 34.61 | 26051181 | |
341 | Ubiquitination | EIDEIHSKYRKKHKS HHHHHHHHHHHHCHH | 34.61 | 23000965 | |
344 | Ubiquitination | EIHSKYRKKHKSEFQ HHHHHHHHHCHHHHH | 57.02 | 23000965 | |
345 | Ubiquitination | IHSKYRKKHKSEFQL HHHHHHHHCHHHHHH | 47.47 | 23000965 | |
347 | Sumoylation | SKYRKKHKSEFQLLV HHHHHHCHHHHHHHH | 61.64 | - | |
347 | Sumoylation | SKYRKKHKSEFQLLV HHHHHHCHHHHHHHH | 61.64 | - | |
347 | Ubiquitination | SKYRKKHKSEFQLLV HHHHHHCHHHHHHHH | 61.64 | 23000965 | |
348 | Phosphorylation | KYRKKHKSEFQLLVD HHHHHCHHHHHHHHH | 43.28 | 28555341 | |
362 | Ubiquitination | DQARKGYKKIAGMSQ HHHHHHHHHHHCCCC | 46.50 | - | |
363 | Ubiquitination | QARKGYKKIAGMSQK HHHHHHHHHHCCCCC | 29.34 | 29967540 | |
368 | Phosphorylation | YKKIAGMSQKTVTIT HHHHHCCCCCEEEEE | 27.83 | 23403867 | |
370 | Sumoylation | KIAGMSQKTVTITKE HHHCCCCCEEEEECC | 37.34 | - | |
370 | Acetylation | KIAGMSQKTVTITKE HHHCCCCCEEEEECC | 37.34 | 71255 | |
370 | Sumoylation | KIAGMSQKTVTITKE HHHCCCCCEEEEECC | 37.34 | - | |
370 | Ubiquitination | KIAGMSQKTVTITKE HHHCCCCCEEEEECC | 37.34 | 22817900 | |
375 | Phosphorylation | SQKTVTITKEDESTE CCCEEEEECCCCCCH | 21.00 | 23403867 | |
376 | Sumoylation | QKTVTITKEDESTEK CCEEEEECCCCCCHH | 60.36 | - | |
376 | Acetylation | QKTVTITKEDESTEK CCEEEEECCCCCCHH | 60.36 | 26051181 | |
376 | Sumoylation | QKTVTITKEDESTEK CCEEEEECCCCCCHH | 60.36 | 28112733 | |
376 | Ubiquitination | QKTVTITKEDESTEK CCEEEEECCCCCCHH | 60.36 | 21906983 | |
380 | Phosphorylation | TITKEDESTEKLSSV EEECCCCCCHHHHHH | 54.94 | 20860994 | |
383 | Ubiquitination | KEDESTEKLSSVCMG CCCCCCHHHHHHHCC | 54.48 | 21963094 | |
385 | Phosphorylation | DESTEKLSSVCMGQE CCCCHHHHHHHCCCC | 31.62 | 20068231 | |
386 | Phosphorylation | ESTEKLSSVCMGQED CCCHHHHHHHCCCCC | 29.76 | 30576142 | |
396 | Phosphorylation | MGQEDNMTSVTNHFS CCCCCCCHHHHHCCC | 26.71 | 20068231 | |
397 | Phosphorylation | GQEDNMTSVTNHFSQ CCCCCCHHHHHCCCH | 19.04 | 30576142 | |
399 | Phosphorylation | EDNMTSVTNHFSQSK CCCCHHHHHCCCHHH | 23.81 | 30576142 | |
403 | Phosphorylation | TSVTNHFSQSKLDSP HHHHHCCCHHHCCCH | 26.45 | 17525332 | |
405 | Phosphorylation | VTNHFSQSKLDSPEE HHHCCCHHHCCCHHH | 33.71 | 25159151 | |
409 | Phosphorylation | FSQSKLDSPEELEPD CCHHHCCCHHHCCCC | 44.65 | 29255136 | |
434 | Phosphorylation | IQEVLSSSESDSCNS HHHHHHCCCCCCCCC | 37.43 | 21098111 | |
460 | Phosphorylation | EEEAWEASHKNDLQD HHHHHHHHHHCCCCC | 24.39 | 26074081 | |
462 | Ubiquitination | EAWEASHKNDLQDTE HHHHHHHHCCCCCCC | 50.06 | 21906983 | |
468 | O-linked_Glycosylation | HKNDLQDTEISPRQN HHCCCCCCCCCHHHC | 23.43 | 30379171 | |
468 | Phosphorylation | HKNDLQDTEISPRQN HHCCCCCCCCCHHHC | 23.43 | 23927012 | |
471 | Phosphorylation | DLQDTEISPRQNRRT CCCCCCCCHHHCHHH | 14.06 | 19664994 | |
478 | Phosphorylation | SPRQNRRTRAAESAE CHHHCHHHHHHHHHC | 22.79 | 26074081 | |
483 | Phosphorylation | RRTRAAESAEIEPRN HHHHHHHHHCCCCCC | 26.86 | 25218447 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
99 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
403 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
434 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | RAD18 | Q9NS91 | PMID:15509568 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RAD18_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RAD18_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-103; SER-322 ANDSER-471, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158; SER-164 ANDSER-471, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-103; THR-118;SER-158 AND SER-164, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-107, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409 AND SER-471, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-409 AND SER-471,AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-118 AND SER-471, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-471, AND MASSSPECTROMETRY. |